Dyne Therapeutics, Inc. (DYN)
NASDAQ·Healthcare·Biotechnology
$18.11
-1.63%
Mkt Cap $4.53B
Analyst Ratings
Buy
6
Hold
0
Sell
1
Price Target (31 analysts)
$35.50
Range $24.00 – $47.00
Implied Upside
+96.1%
Consensus $35.50 vs current $18.11
NASDAQ·Healthcare·Biotechnology
$18.11
-1.63%
Mkt Cap $4.53B
Buy
6
Hold
0
Sell
1
Price Target (31 analysts)
$35.50
Range $24.00 – $47.00
+96.1%
Consensus $35.50 vs current $18.11